Generalized mantle cell Lymphoma research hub

TRIANGLE - autologous Transplantation after a Rituximab/Ibrutinib/Ara-c containing iNduction in Generalized mantle cell Lymphoma – a randomized European mcl network trial

This study looks at new ways to treat a type of cancer called mantle cell lymphoma. It compares standard treatment with a new approach using the drug ibrutinib, to see if it helps patients live longer without their cancer getting worse.